Cargando…
Global regulatory progress in delivering on the promise of gene therapies for unmet medical needs
The rapid expansion of the gene therapy pipeline in recent years offers significant potential to treat diseases with great unmet medical need. However, the unique nature of these therapies poses challenges to regulating them within traditional frameworks, even when developing in a single country. Va...
Autores principales: | Drago, Daniela, Foss-Campbell, Betsy, Wonnacott, Keith, Barrett, David, Ndu, Adora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099595/ https://www.ncbi.nlm.nih.gov/pubmed/33997101 http://dx.doi.org/10.1016/j.omtm.2021.04.001 |
Ejemplares similares
-
Assessing unmet medical need in India: A regulatory riddle?
por: Bhatt, Arun
Publicado: (2015) -
The Use of External Controls in FDA Regulatory Decision Making
por: Jahanshahi, Mahta, et al.
Publicado: (2021) -
The promise and challenge of personalized medicine: aging populations, complex diseases, and unmet medical need
por: Henney, Adriano M
Publicado: (2012) -
Global economic burden of unmet surgical need for appendicitis
por: Reuter, Anna, et al.
Publicado: (2022) -
Innovations in the diagnosis and management of uveitis: promising research to address unmet patient needs
por: Yeh, Steven, et al.
Publicado: (2022)